Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Autophagy as a cytoprotective mechanism in esophageal squamous cell carcinoma.

Hall TM, T├ętreault MP, Hamilton KE, Whelan KA.

Curr Opin Pharmacol. 2018 Aug;41:12-19. doi: 10.1016/j.coph.2018.04.003. Epub 2018 Apr 17. Review.

2.

Increased Numb protein expression predicts poor clinical outcomes in esophageal squamous cell carcinoma patients.

Liu Z, Luo C, Yang W, Wang K, Hu C, Zou J, Zhu H, Fu L, Nie J, Cheng C.

Cancer Biol Ther. 2018 Jan 2;19(1):34-41. doi: 10.1080/15384047.2016.1276131. Epub 2017 Dec 18.

3.

Autophagy and Apoptosis Play Opposing Roles in Overall Survival of Esophageal Squamous Cell Carcinoma.

Chen HI, Tsai HP, Chen YT, Tsao SC, Chai CY.

Pathol Oncol Res. 2016 Oct;22(4):699-705. doi: 10.1007/s12253-016-0051-z. Epub 2016 Mar 15.

PMID:
26980476
4.

Targeted therapy of esophageal squamous cell carcinoma: the NRF2 signaling pathway as target.

Ma S, Paiboonrungruan C, Yan T, Williams KP, Major MB, Chen XL.

Ann N Y Acad Sci. 2018 Dec;1434(1):164-172. doi: 10.1111/nyas.13681. Epub 2018 May 11. Review.

PMID:
29752726
5.

Nrf2 and Keap1 abnormalities in esophageal squamous cell carcinoma and association with the effect of chemoradiotherapy.

Zhang J, Jiao Q, Kong L, Yu J, Fang A, Li M, Yu J.

Thorac Cancer. 2018 Jun;9(6):726-735. doi: 10.1111/1759-7714.12640. Epub 2018 Apr 19.

6.

Expression analysis of cyclooxygenase-2 in patients suffering from esophageal squamous cell carcinoma.

Tasneem S, Sarwar MT, Bashir MR, Hussain H, Ahmed J, Pervez S.

PLoS One. 2018 Oct 19;13(10):e0205508. doi: 10.1371/journal.pone.0205508. eCollection 2018.

7.

B7H4 is associated with stemness and cancer progression in esophageal squamous cell carcinoma.

Piao L, Yang Z, Jin J, Ni W, Qi W, Xuan Y.

Hum Pathol. 2018 Oct;80:152-162. doi: 10.1016/j.humpath.2018.05.021. Epub 2018 Jun 6.

PMID:
29885401
8.

Risk factors for esophageal fistula in thoracic esophageal squamous cell carcinoma invading adjacent organs treated with definitive chemoradiotherapy: a monocentric case-control study.

Kawakami T, Tsushima T, Omae K, Ogawa H, Shirasu H, Kito Y, Yoshida Y, Hamauchi S, Todaka A, Machida N, Yokota T, Yamazaki K, Fukutomi A, Onozawa Y, Yasui H.

BMC Cancer. 2018 May 18;18(1):573. doi: 10.1186/s12885-018-4486-3.

9.

Multi-region sequencing unveils novel actionable targets and spatial heterogeneity in esophageal squamous cell carcinoma.

Yan T, Cui H, Zhou Y, Yang B, Kong P, Zhang Y, Liu Y, Wang B, Cheng Y, Li J, Guo S, Xu E, Liu H, Cheng C, Zhang L, Chen L, Zhuang X, Qian Y, Yang J, Ma Y, Li H, Wang F, Liu J, Liu X, Su D, Wang Y, Sun R, Guo S, Li Y, Cheng X, Liu Z, Zhan Q, Cui Y.

Nat Commun. 2019 Apr 11;10(1):1670. doi: 10.1038/s41467-019-09255-1.

10.

ISG15 promotes esophageal squamous cell carcinoma tumorigenesis via c-MET/Fyn/╬▓-catenin signaling pathway.

Yuan H, Zhou W, Yang Y, Xue L, Liu L, Song Y.

Exp Cell Res. 2018 Jun 1;367(1):47-55. doi: 10.1016/j.yexcr.2018.03.017. Epub 2018 Mar 17.

PMID:
29555370
11.

Aberrant methylation-mediated silencing of lncRNA CTC-276P9.1 is associated with malignant progression of esophageal squamous cell carcinoma.

Guo W, Liu S, Dong Z, Guo Y, Ding C, Shen S, Liang J, Shan B.

Clin Exp Metastasis. 2018 Feb;35(1-2):53-68. doi: 10.1007/s10585-018-9881-2. Epub 2018 Mar 10.

PMID:
29524086
12.

High Expression of the Mitophagy-Related Protein Pink1 is Associated with a Poor Response to Chemotherapy and a Poor Prognosis for Patients Treated with Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma.

Yamashita K, Miyata H, Makino T, Masuike Y, Furukawa H, Tanaka K, Miyazaki Y, Takahashi T, Kurokawa Y, Yamasaki M, Nakajima K, Takiguchi S, Morii E, Mori M, Doki Y.

Ann Surg Oncol. 2017 Dec;24(13):4025-4032. doi: 10.1245/s10434-017-6096-8. Epub 2017 Oct 11.

PMID:
29022200
13.

The AXL receptor tyrosine kinase is associated with adverse prognosis and distant metastasis in esophageal squamous cell carcinoma.

Hsieh MS, Yang PW, Wong LF, Lee JM.

Oncotarget. 2016 Jun 14;7(24):36956-36970. doi: 10.18632/oncotarget.9231.

14.

HCRP1 inhibits cell proliferation and invasion and promotes chemosensitivity in esophageal squamous cell carcinoma.

Wu Y, Yang Y, Xian YS.

Chem Biol Interact. 2019 Aug 1;308:357-363. doi: 10.1016/j.cbi.2019.05.032. Epub 2019 May 29.

PMID:
31152734
15.

Resveratrol-induced apoptosis is enhanced by inhibition of autophagy in esophageal squamous cell carcinoma.

Tang Q, Li G, Wei X, Zhang J, Chiu JF, Hasenmayer D, Zhang D, Zhang H.

Cancer Lett. 2013 Aug 19;336(2):325-37. doi: 10.1016/j.canlet.2013.03.023. Epub 2013 Mar 27.

PMID:
23541682
16.

TDO2 Overexpression Is Associated with Cancer Stem Cells and Poor Prognosis in Esophageal Squamous Cell Carcinoma.

Pham QT, Oue N, Sekino Y, Yamamoto Y, Shigematsu Y, Sakamoto N, Sentani K, Uraoka N, Yasui W.

Oncology. 2018;95(5):297-308. doi: 10.1159/000490725. Epub 2018 Aug 22.

PMID:
30134247
17.

Immunotherapy for esophageal squamous cell carcinoma: a review.

Mimura K, Yamada L, Ujiie D, Hayase S, Tada T, Hanayama H, Thar Min AK, Shibata M, Momma T, Saze Z, Ohki S, Kono K.

Fukushima J Med Sci. 2018 Aug 29;64(2):46-53. doi: 10.5387/fms.2018-09. Epub 2018 Jul 27. Review.

18.

Immunotherapy of Esophageal Cancer: Current Status, Many Trials and Innovative Strategies.

Alsina M, Moehler M, Lorenzen S.

Oncol Res Treat. 2018;41(5):266-271. doi: 10.1159/000488120. Epub 2018 Apr 20. Review.

19.

EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition.

Sato F, Kubota Y, Natsuizaka M, Maehara O, Hatanaka Y, Marukawa K, Terashita K, Suda G, Ohnishi S, Shimizu Y, Komatsu Y, Ohashi S, Kagawa S, Kinugasa H, Whelan KA, Nakagawa H, Sakamoto N.

Cancer Biol Ther. 2015;16(6):933-40. doi: 10.1080/15384047.2015.1040959. Epub 2015 Apr 21.

20.

Cancer stem cells in esophageal cancer and response to therapy.

Harada K, Pool Pizzi M, Baba H, Shanbhag ND, Song S, Ajani JA.

Cancer. 2018 Oct 15;124(20):3962-3964. doi: 10.1002/cncr.31697. Epub 2018 Oct 25. Review. No abstract available.

PMID:
30368777

Supplemental Content

Support Center